Literature DB >> 12748291

PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins.

Benjamin Deneen1, Scott M Welford, Thu Ho, Felicia Hernandez, Irwin Kurland, Christopher T Denny.   

Abstract

Despite significant structural diversity, present evidence suggests that EWS/ETS fusion proteins promote oncogenesis by transcriptionally modulating a common set of target genes. In order to identify these genes, microarray expression analyses were performed on NIH 3T3 polyclonal populations expressing one of three EWS/ETS fusion genes. The majority of these genes can be grouped into seven functional categories, including cellular metabolism and signal transduction. The biologic significance of these target genes was pursued. The effects of modulating genes involved in metabolism were assessed by flux studies and demonstrated shifts in glucose utilization and lactate production as a result of EWS/FLI1 expression. The proto-oncogene coding for serine/threonine kinase PIM3 was found to one of several genes encoding signal transduction proteins that were up-regulated by EWS/ETS fusions. PIM3 was found to be expressed in a panel of human Ewing's family tumor cell lines. Forced expression of PIM3 promoted anchorage-independent growth. Coexpression of a kinase-deficient PIM3 mutant attenuated EWS/FLI1-mediated NIH 3T3 tumorigenesis in immunodeficent mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748291      PMCID: PMC155223          DOI: 10.1128/MCB.23.11.3897-3908.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).

Authors:  I Panagopoulos; M Mencinger; C U Dietrich; B Bjerkehagen; G Saeter; F Mertens; N Mandahl; S Heim
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

Review 2.  Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family.

Authors:  E de Alava; W L Gerald
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 3.  Signaling through Gp130: toward a general scenario of cytokine action.

Authors:  T Fukada; Y Yoshida; K Nishida; T Ohtani; T Shirogane; M Hibi; T Hirano
Journal:  Growth Factors       Date:  1999       Impact factor: 2.511

4.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.

Authors:  T Shirogane; T Fukada; J M Muller; D T Shima; M Hibi; T Hirano
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

5.  Characterization of mouse glycogenin-1 cDNA and promoter region.

Authors:  M van Maanen; P A Fournier; T N Palmer; L J Abraham
Journal:  Biochim Biophys Acta       Date:  1999-10-28

6.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

Authors:  H A Coller; C Grandori; P Tamayo; T Colbert; E S Lander; R N Eisenman; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

7.  Identification and characterization of collaborating oncogenes in compound mutant mice.

Authors:  A Berns; H Mikkers; P Krimpenfort; J Allen; B Scheijen; J Jonkers
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

8.  Cell cycle-regulated proteolysis of mitotic target proteins.

Authors:  H Bastians; L M Topper; G L Gorbsky; J V Ruderman
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

9.  A novel zinc finger gene is fused to EWS in small round cell tumor.

Authors:  T Mastrangelo; P Modena; S Tornielli; F Bullrich; M A Testi; A Mezzelani; P Radice; A Azzarelli; S Pilotti; C M Croce; M A Pierotti; G Sozzi
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

10.  Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.

Authors:  C Attwooll; M Tariq; M Harris; J D Coyne; N Telford; J M Varley
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

View more
  21 in total

Review 1.  Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Authors:  Stephen L Lessnick; Marc Ladanyi
Journal:  Annu Rev Pathol       Date:  2011-09-19       Impact factor: 23.472

2.  PI3K-like kinases restrain Pim gene expression in endothelial cells.

Authors:  Xinwen Min; Jie Tang; Yinfang Wang; Minghua Yu; Libing Zhao; Handong Yang; Peng Zhang; Yexin Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

3.  The oncogenic TLS-ERG fusion protein exerts different effects in hematopoietic cells and fibroblasts.

Authors:  Junhui Zou; Hitoshi Ichikawa; Michael L Blackburn; Hsien-Ming Hu; Anna Zielinska-Kwiatkowska; Qi Mei; Gerald J Roth; Howard A Chansky; Liu Yang
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.

Authors:  Yoshitaka Miyagawa; Hajime Okita; Hideki Nakaijima; Yasuomi Horiuchi; Ban Sato; Tomoko Taguchi; Masashi Toyoda; Yohko U Katagiri; Junichiro Fujimoto; Jun-Ichi Hata; Akihiro Umezawa; Nobutaka Kiyokawa
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

5.  Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.

Authors:  Dapeng Xu; Michael G Cobb; Lily Gavilano; Sam M Witherspoon; Daniel Williams; Catherine D White; Pietro Taverna; Brian K Bednarski; Hong Jin Kim; Albert S Baldwin; Antonio T Baines
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

Review 6.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

Review 7.  PIM kinase (and Akt) biology and signaling in tumors.

Authors:  Noel A Warfel; Andrew S Kraft
Journal:  Pharmacol Ther       Date:  2015-03-05       Impact factor: 12.310

8.  EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.

Authors:  Enrique C Torchia; Kelli Boyd; Jerold E Rehg; Chunxu Qu; Suzanne J Baker
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

9.  Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.

Authors:  Hua-Chuan Zheng; Koichi Tsuneyama; Hiroyuki Takahashi; Shigeharu Miwa; Toshiro Sugiyama; Boryana Konstantinova Popivanova; Chifumi Fujii; Kazuhiro Nomoto; Naofumi Mukaida; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-18       Impact factor: 4.553

10.  Protein disorder in the human diseasome: unfoldomics of human genetic diseases.

Authors:  Uros Midic; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  BMC Genomics       Date:  2009-07-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.